Everything below concerns Dipeptidyl peptidase-4. We keep the language plain, cite what the science says, and separate well-supported claims from open questions.
Last reviewed on 2025-11-19. Where a claim depends on a specific study, the study is described rather than over-claimed.
Signaling begins at the GHRH receptor, a class B G protein-coupled receptor displayed on somatotroph cells of the anterior pituitary. Receptor occupancy activates Gs proteins, which raise adenylyl cyclase activity and intracellular cyclic AMP, in turn driving protein kinase A dependent pathways. The downstream output is synthesis and pulsatile secretion of growth hormone into the bloodstream. Hepatic tissue and peripheral sites respond by increasing insulin-like growth factor 1 production. Somatostatin and IGF-1 itself supply negative feedback that caps the size and duration of each secretory burst.
Metabolic interest in this compound centers on fat distribution rather than on hormone levels alone. Imaging trials in adults with excess abdominal fat report reductions in visceral adipose tissue, while subcutaneous depots change comparatively little. Growth hormone and IGF-1 are presumed to carry the effect, but the separate contribution of each is not firmly established. Whether these changes persist after treatment stops, and whether they alter longer-term health outcomes, remain open questions that published work does not answer consistently.
Tesamorelin is a synthetic peptide of forty-four amino acids whose sequence reproduces human growth hormone-releasing hormone. Its distinguishing feature sits at the amino terminus, where a trans-3-hexenoyl group replaces the free amine. That acylation slows cleavage by dipeptidyl peptidase IV, an enzyme that otherwise removes the first two residues and inactivates the natural hormone quickly. The modified peptide therefore persists longer in circulation while keeping the same receptor target. It is handled as a lyophilized solid and dissolved shortly before use.
Pharmacodynamic studies show that tesamorelin reduces visceral adipose tissue more than subcutaneous adipose tissue in the studied population. This selectivity may relate to differences in blood flow and hormone sensitivity between fat depots. Effects on glucose metabolism and insulin sensitivity have been investigated, with some trials reporting modest changes and others showing stability. The precise relationship between growth hormone exposure, IGF-1 levels, and visceral fat loss remains an active area of analysis.
Tesamorelin binds to growth hormone-releasing hormone receptors on somatotroph cells in the anterior pituitary. Receptor activation increases intracellular cyclic AMP and promotes synthesis and secretion of growth hormone. Because the peptide mimics endogenous GHRH, it amplifies the normal pulsatile release of growth hormone rather than providing exogenous growth hormone directly. This upstream action distinguishes tesamorelin from recombinant growth hormone preparations and from growth hormone secretagogues that act at different receptors.
Stimulated growth hormone release leads to hepatic production of insulin-like growth factor 1, a key mediator of many growth hormone effects. In clinical studies, tesamorelin increased IGF-1 levels in a dose-dependent manner, although the response varies among individuals. The drug's effect on visceral fat is thought to involve growth hormone-mediated lipolysis and altered adipocyte metabolism. Muscle mass and lean body mass have also been assessed as secondary outcomes, but changes are generally smaller and less consistent than fat reductions.
| Property | Value | Notes |
|---|---|---|
| Molecular class | Synthetic 44-residue peptide | GHRH analog backbone |
| Approximate molecular mass | 5136 Da | Varies with counterion and hydration state |
| N-terminal group | trans-3-hexenoyl | Increases resistance to dipeptidyl peptidase IV |
| Primary receptor | GHRH receptor (GHRHR) | Class B G protein-coupled receptor on somatotrophs |
| Principal mediator | IGF-1 | Rises indirectly after growth hormone release |
Receptor-level activity begins when the peptide binds the GHRH receptor, a class B G-protein-coupled receptor found on pituitary somatotroph cells. Occupancy triggers Gs-mediated activation of adenylyl cyclase and a rise in intracellular cyclic AMP, which in turn promotes synthesis and pulsatile release of growth hormone. Because the compound acts upstream of the growth hormone axis rather than supplying hormone directly, its effect depends on intact pituitary function. Binding studies in cell culture and animal models have established this pathway; the detailed kinetics of receptor recycling in humans remain less well characterized.
Physicochemical behavior is dominated by the peptide backbone. The molecule is hydrophilic and carries a net positive charge near neutral pH, owing to several arginine and lysine residues. In solution it adopts a largely unstructured conformation, and aggregation is a known concern for peptide products of this size. Oxidation of methionine and deamidation of asparagine or glutamine residues are the principal chemical degradation routes. These liabilities shape how the material is formulated, handled, and analyzed, and they explain why lyophilized presentations are common in research settings.
Whether the drug improves hard clinical outcomes is not settled. No completed trial has shown a reduction in heart attacks or strokes among treated patients, although a dedicated cardiovascular outcomes study has been discussed in the literature. Investigators have also examined hepatic fat in people with HIV and fatty liver disease, cognitive measures in small cohorts, and changes in bone density. Regulatory labeling emphasizes monitoring of insulin-like growth factor 1 because supraphysiologic levels raise questions about tissue growth, and the clinical significance of that signal remains an open question rather than a demonstrated harm.
Binding of tesamorelin to the growth hormone-releasing hormone receptor on anterior pituitary somatotrophs activates a Gs protein pathway, raises cyclic AMP, and triggers release of stored growth hormone into the bloodstream. Because the analogue resists dipeptidyl peptidase-4, its plasma residence time exceeds that of native GHRH, producing a larger and more sustained secretory signal. The released growth hormone then acts on the liver and peripheral tissues to raise insulin-like growth factor 1, which feeds back on the hypothalamus and pituitary. This axis explains both the intended effects on fat distribution and the biological markers used to track them.
The hexenoyl cap slows the enzyme step that trims the amino terminus of native GHRH, the same step that shortens its active lifetime in circulation. As a result, the modified peptide persists longer in plasma than the unmodified hormone in side-by-side comparison. Receptor activity stays broadly comparable, because the added group sits away from the residues that contact the binding site. This combination, preserved receptor activity with reduced degradation, explains why the analog was developed instead of the native sequence.
Several compounds share the GHRH framework, including sermorelin, the shorter 1-29 fragment, and other analogs built on the full 1-44 chain. Naming follows a common convention: a stem that identifies the peptide plus a suffix marking analog status. Reports may describe tesamorelin by its sequence fragment, as a GHRH(1-44) analog, or by its amino-terminal modification. Indexing the compound therefore requires searching all of these forms, since some older literature predates the current international nonproprietary name.
== Further reading == Aikin, Jane (2010). "Histories of the Library of Congress". Libraries & the Cultural Record. 45 (1): 5–24. doi:10.1353/lac.0.0113. S2CID 161865550. Anderson, Gillian B. (1989), "Putting the Experience of the World at the Nation's Command: Music at the Library of Congress, 1800–1917", Journal of the American Musicological Society, 42 (1): 108–49, doi:10.2307/831419, JSTOR 831419 Bisbort, Alan, and Linda Barrett Osborne. The Nation's Library: The Library of Congress, Washington, D. C. (Library of Congress, 2000) Cole, John Young. Jefferson's legacy: a brief history of the Library of Congress (Library of Congress, 1993) Cole, John Young. "The library of congress becomes a world library, 1815–2005." Libraries & culture (2005) 40#3: 385–398. in Project MUSE Cope, R. L. "Management Review of the Library of Congress: The 1996 Booz Allen & Hamilton Report," Australian Academic & Research Libraries (1997) 28#1 online Mearns, David Chambers. The Story Up to Now: The Library of Congress, 1800–1946 (1947), detailed narrative Ostrowski, Carl. Books, Maps, and Politics: A Cultural History of the Library of Congress, 1783–1861 (2004) Rosenberg, Jane Aiken. The Nation's Great Library: Herbert Putnam and the Library of Congress, 1899–1939 (University of Illinois Press, 1993) Shevlin, Eleanor F.; Lindquist, Eric N. (2010). "The Center for the Book and the History of the Book". Libraries & the Cultural Record. 45 (1): 56–69. doi:10.1353/lac.0.0112. S2CID 161311744. Tabb, Winston; et al. (2003). "Library of Congress". Encyclopedia of Library and Information Science.
Replacing natural polyunsaturated fatty acids (PUFA) with deuterated PUFA (dPUFA), which have deuterium in place of the bis-allylic hydrogens, can prevent cell death induced by erastin or RSL3. These deuterated PUFAs effectively inhibit ferroptosis and various chronic degenerative diseases associated with ferroptosis. Live-cell imaging has been used to observe the morphological changes that cells undergo during ferroptosis. Initially the cell contracts and then begins to swell. Perinuclear lipid assembly is observed immediately before ferroptosis occurs. After the process is complete, lipid droplets are redistributed throughout the cell (see GIF on right side).
Subsequent clinical research has found that monotherapy with higher dosages of NSAAs than those used in CAB is roughly equivalent to castration in extending life in men with prostate cancer. Moreover, NSAA monotherapy is overall better tolerated and associated with greater quality of life than is castration, which is thought to be related to the fact that testosterone levels do not decrease with NSAA monotherapy and hence by extension that levels of biologically active and beneficial metabolites of testosterone such as estrogens and neurosteroids are preserved. For these reasons, NSAA monotherapy has become an important alternative to castration and CAB in the treatment of prostate cancer. Bicalutamide may be used to reduce the effects of the testosterone flare at the initiation of GnRH agonist therapy. The combination of bicalutamide with an estrogen such as ethinylestradiol sulfonate has been used as a form of CAB and as an alternative to the combination of bicalutamide with surgical or medical castration.
==== Internal ==== The phylogeny of the Asteroidea has been difficult to resolve, with visible (morphological) features proving inadequate, and the question of whether traditional taxa are clades apply. The phylogeny proposed by Gale in 1987 is:
== Background == Founded in 1989 by Jaba Ioseliani, the Mkhedrioni presented itself as the heir to historic Georgian guerrilla groups who fought Iranian and Ottoman occupiers. The group's name literally means "horsemen", but in Georgian it has a meaning closer to "knights" (this alternative translation has occasionally been used). Each member of the organization would take an oath to defend Georgia's people, the Georgian Orthodox and Apostolic Church and Georgia's land, and wore a medallion with a scene of Saint George slaying the dragon on one side and the bearer's name and blood type on the other. The establishment of the Mkhedrioni took place as Georgia moved towards independence in the final years of the Soviet Union. Relations between Georgian nationalists and the country's national minorities, especially the Abkhaz and Ossetians, were difficult at best even during Soviet rule and grew more tense during the rise to power of the nationalist dissident Zviad Gamsakhurdia. The Mkhedrioni was one of a number of nationalist paramilitary groups established during this period as a counterbalance to similar paramilitary organisations set up by rival nationalists elsewhere in Georgia. The Mkhedrioni's members gained an unpleasant reputation as heavily armed thugs who engaged in violent intimidation of their rivals. They were highly visible, wearing what amounted to a uniform of jeans, sweaters and jackets, topped off by sunglasses (even worn indoors). Leaders wore Armani suits bulging with guns, according to one author.
Sources: en.wikipedia.org
== Dye chemistry == Variations in colours of "Tyrian purple" from different snails are related to the presence of indigo dye (blue), 6-bromoindigo (purple), and the red 6,6'-dibromoindigo. Additional changes in colour can be induced by debromination from light exposure (as is the case for Tekhelet) or by heat processing. The final shade of purple is decided by chromatogram, which can be identified by high performance liquid chromatography analysis in a single measurement: indigotin (IND) and indirubin (INR). The two are found in plant sources such as woad (Isatis tinctoria L.) and the indigo plant (Indigofera tinctoria L), as well as in several species of shellfish. In 1998, by means of a lengthy trial and error process, a process for dyeing with Tyrian purple was rediscovered. This finding built on reports from the 15th century to the 18th century and explored the biotechnology process behind woad fermentation. It is hypothesized that an alkaline fermenting vat was necessary. An incomplete ancient recipe for Tyrian purple recorded by Pliny the Elder was also consulted. By altering the percentage of sea salt in the dye vat and adding potash, he was able to successfully dye wool a deep purple colour. Recent research in organic electronics has shown that Tyrian purple is an ambipolar organic semiconductor. Transistors and circuits based on this material can be produced from sublimed thin-films of the dye. The good semiconducting properties of the dye originate from strong intermolecular hydrogen bonding that reinforces pi stacking necessary for transport.
== External links == Understanding Pompe Disease - US National Institute of Arthritis and Musculoskeletal and Skin Diseases AGSD — Association of Glycogen Storage Disease in the United States AGSD-UK — Association of Glycogen Storage Disease in the UK AMDA — Acid Maltase Deficiency Association (Pompe disease) IPA — International Pompe Association IamGSD — International Association for Muscle Glycogen Storage Disease
By the end of season 9 they virtually replaced the Syndicate and were successful in chasing Mulder and Scully out of the FBI so that they can no longer investigate the X-Files and interfere with their plans. As of their last appearance, they were preparing for the final invasion in 2012.
CH3OH + H2S → CH3SH + H2O Such reactions are conducted in the presence of acidic catalysts. The other principal route to thiols involves the addition of hydrogen sulfide to alkenes. Such reactions are usually conducted in the presence of an acid catalyst or UV light. Halide displacement, using the suitable organic halide and sodium hydrogen sulfide has also been used. Another method entails the alkylation of sodium hydrosulfide.
Sources: en.wikipedia.org
Nicotiana tabacum, or cultivated tobacco, is an annually grown herbaceous plant of the genus Nicotiana. N. tabacum is the most commonly grown species in the genus Nicotiana, as the plant's leaves are commercially harvested to be processed into tobacco for human use. The plant is native to Bolivia, commonly grown throughout the world and often found in cultivation. It grows to heights between 1 and 2 metres (3.3 and 6.6 ft). Research is ongoing into its ancestry among wild Nicotiana species, but it is believed to be a hybrid of Nicotiana sylvestris, N. tomentosiformis, and possibly N. otophora.
=== Other uses === Risperidone has demonstrated clinical benefit as an augmentation agent in the management of (unipolar) non-psychotic treatment-resistant depression alongside antidepressant treatment. Atypical antipsychotics, such as risperidone, are among the most common augments for antidepressant therapy. Such usage occurs off-label in most jurisdictions and the risk of adverse effects (e.g., weight gain, movement disorders) must be carefully weighed against the clinical benefit. Risperidone has shown promise in treating therapy-resistant obsessive–compulsive disorder, when serotonin reuptake inhibitors alone are not sufficient. Risperidone has proven to be effective in treatment of aggression associated with attention deficit hyperactivity disorder (ADHD), or with another mental condition. Risperidone has not demonstrated a benefit in the treatment of eating disorders or personality disorders, except for limited evidence in schizotypal personality disorder.
An advertising poster featuring a picture of Michelangelo's David is removed from the Glasgow Subway at the request of the owners of the advertising space because of its nudity. It is replaced with an edited version hiding the crotch region. 20 May – The Annual General Meeting of the General Assembly of the Church of Scotland hears that hundreds of churches may have to close as a result of falling numbers of attendees and income. 21 May – Ten people are injured, and two are taken to hospital, after a bus crashes into a bridge in Glasgow and has its roof torn off. 22 May The Scottish Government offers junior doctors in Scotland a 14.5% pay rise. Margaret Ferrier loses her appeal against a proposed 30 day ban from the House of Commons over her breach of COVID-19 rules in September 2020. 24 May Following a hearing at the High Court in Edinburgh, Rhys Bennett is sentenced to life imprisonment with a minimum of 24 years for the rape and murder of Jill Barclay as she walked home in Aberdeen in September 2022. A group of eight former SNP councillors in North Lanarkshire form a new political party, Progressive Change NL, which becomes North Lanarkshire Council's second largest opposition party. 25 May – Responding to the outcome of a review of Police Scotland, its chief constable, Sir Ian Livingstone, says the force is institutionally sexist, racist and discriminatory.
Luria–Nebraska Neuropsychological Battery A standardized test battery used to assess a wide range of cognitive and motor functions. Based on the work of Alexander Luria, it helps localize brain dysfunction.
Former interim leader of the party and MLA for Surrey-White Rock Trevor Halford, former leader and MLA for Nechako Lakes John Rustad, and MLA for Skeena Claire Rattée were all removed. Rattée issued a statement claiming Findlay was “attempting to oust members of her own caucus, demonstrating poor judgement that doesn’t befit someone who is attempting to become premier.” Since July 2026, multiple staffers have also resigned from the party, including former executive director Angelo Isidorou, former party president Aisha Estey and former vice-president Sharon White. These positions have been replaced by many controversial figures, including Apollo Chung, a former member of the separatist Republican Party of Alberta, and Chris Delaney, notable for his ties to former British Columbia Premier Bill Vander Zalm. In September 2026, allegations emerged that Findlay had hired a private investigator to watch Conservative critics, including sitting Conservative MLAs and a journalist. Findlay claims she was "unaware." MLA for Skeena Claire Rattée, who identified herself as one of the targets, said at least 10 members of caucus have signed a letter asking Findlay to resign. Rattée was later removed from caucus by Findlay. Former Conservative MLA Brennan Day, and former party executive director Angelou Isidorou also identified themselves as alleged targets. On September 20, 2026, Findlay announced her resignation as leader of the Conservative Party of BC.
Sources: en.wikipedia.org
The amino acid sequence matches human growth hormone-releasing hormone, but the amino terminus carries a trans-3-hexenoyl group instead of a free amine. That single structural change chiefly affects enzymatic stability rather than receptor selectivity.
Growth hormone released from the pituitary stimulates IGF-1 production in the liver and other tissues, so circulating IGF-1 generally rises during exposure. The size of the rise varies between individuals and depends on baseline hormonal status and other concurrent factors.
Reported imaging studies focus on visceral adipose tissue, where reductions are more consistently observed across trials. Subcutaneous depots show smaller and less reproducible changes, so the two compartments should not be treated as equivalent.
It targets the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Binding stimulates cyclic AMP signaling and growth hormone secretion. This is the same receptor used by endogenous GHRH.